Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"

Circulation. 2014 Nov 25;130(22):e195. doi: 10.1161/CIRCULATIONAHA.114.012350.

¹ Uppsala Clinical Research Center and Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
² Department of Cardiology, J. W. Goethe University, Frankfurt, Germany.
³ Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
⁴ Population Health Research Institute, Hamilton, Ontario, Canada.
⁵ Thomas Jefferson Medical College and the Heart Center, Wynnewood, PA.
⁶ Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT.
⁷ Uppsala Clinical Research Center and Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.

No abstract available

Publication types